Synergy between thrombin and serotonin in inducing vascular smooth muscle cell proliferation

Journal of Laboratory and Clinical Medicine

Volumn 134, Issue 6, 1999, Pages 659-667

  Pakala, Rajbabu ^a   Benedict, Claude ^b  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0033486163     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2143(99)90107-5     Document Type: Article

References (63)

1. 1. Harker LA, Hanson SR, Runge MS. Thrombin hypothesis of thrombus generation and vascular lesion formation. Am J Cardiol 1995;75:12B-7B.
2. 2. Fager G. Thrombin and proliferation of vascular smooth muscle cells. Circ Res 1995;77:645-50.
3. 3. Sarembock IJ, Gertz SD, Gimple LW, Owen RM, Powers ER, Roberts WC. Effectiveness of recombinant desulphato-hirudin in reducing restenosis after balloon angioplasty of atherosclerotic femoral arteries in rabbits. Circulation 1991;84:232-43.
4. 4. Badimon L, Chesebro JH, Badimon JJ. Thrombus formation on ruptured atherosclerotic plaques and rethrombosis on evolving thrombi. Circulation 1992;86(suppl 6):III-74-III-85.
5. 5. Unterberg C, Sandrock D, Nebendahl K, Buchwald AB. Reduced acute thrombus formation results in decreased neointimal proliferation after coronary angioplasty. J Am Coll Cardiol 1995;26:1747-54.
6. 6. Ali MN, Villarreal-Levy G, Schafer AL. The role of thrombin and thrombin inhibitors in coronary angioplasty. Chest 1995;108:1409-19.
7. 7. Bar-Shavit R, Benezra M, Eldor A, Hy-Am E, Fenton JW, Wilner CD, Vlodavsky I. Thrombin immobilized to extracellular matrix is a potent mitogen for vascular smooth muscle cells: nonenzymatic mode of action. Cell Regul 1990;1:453-63.
8. 8. Ross R, Glomset J, Kariya B, Harker L. A platelet dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro. Proc Natl Acad Sci USA 1974;71:1207-10.
9. 9. Harlan JM, Thompson PJ, Ross RR, Vowen-Pope DR α-Thrombin induces the release of platelet-derived growth factor-like molecule(s) by cultured human endothelial cells. J Cell Biol 1986;103:1129-33.
10. 10. Huang CL, Ives HE. Growth inhibition by protein kinase C late in mitogenesis. Nature 1987;329:849-50.
11. 11. Graham DJ, Alexander JJ. The effects of thrombin on bovine aortic endothelial and smooth smooth muscle cells. J Vasc Surg 1990;11:307-12.
12. 12. Kanthou C, Parry G, Wijelath E, Kakkar VV, Demoliou-Mason C. Thrombin-induced proliferation and expression of platelet-derived growth factor α-chain gene in human vascular smooth muscle cells. FEBS Lett 1992;314:143-8.
13. 13. Stouffer GA, Sarembock IJ, McNamara CA, Gimple LW, Owens GK. Thrombin-induced mitogenesis of vascular SMC is partially mediated by autocrine production of PDGF-AA. Am J Physiol 1993;265:C806-11.
14. 14. Bachhuber BG, Sarembock IJ, Gimple LW, McNamara CA, Owens GK. Thrombin-induced mitogenesis in cultured aortic smooth muscle cells requires prolonged thrombin exposure. Am J Physiol 1995;268:C1141-7.
15. 15. Nemecek GM, Coughlin SR, Handley DA, Moskowitz MA. Stimulation of aortic smooth muscle cell mitogenesis by serotonin. Proc Natl Acad Sci USA 1986;83:674-8.
16. 16. Crowley ST, Dempsey EC, Horwitz KB, Horwitz LD. Platelet induced vascular smooth muscle cell proliferation is modulated by the growth amplification factors and adenosine diphosphate. Circulation 1994;90:1908-18.
17. 17. Pakala R, Willerson JT, Benedict CR. Effect of serotonin, thromboxane A2 and specific receptor antagonists on vascular smooth muscle cell proliferation. Circulation 1997;96:2280-6.
18. 18. Friedman RJ, Stemerman MB, Wenz B, Moore S, Gauldie J, Gent M, et al. The effect of thrombocytopenia on experimental arteriosclerotic lesion formation in rabbits: smooth muscle cell proliferation and re-endotheliazation. J Clin Invest 1977;60:1191-201.
19. 19. Walker LN, Bowen-Pope DF, Ross R, Reidy MA. Production of platelet-derived growth factor-like molecules by cultured arterial smooth muscle cells accompanies proliferation after arterial injury. Proc Natl Acad Sci USA 1986;83:7311-5.
20. 20. Lindner V, Lappi DA, Baird A, Majack RA, Reidy MA. Role of fibroblast growth factor in vascular lesion formation. Circ Res 1991;68:106-13.
21. 21. Hatton MWC, Moar SL, Richardson M. Deendothelialization in vivo initiates a thrombogenic reaction at the rabbit aorta surface: correlation of uptake of fibrinogen and antithrombin III with thrombin generation by the exposed subendothelium. Am J Pathol 1989;135:499-508.
22. 22. Wilentz JR, Sanborn TA, Haudenschild CC, Valeri CR, Ryan TJ, Faxon DP. Platelet accumulation in experimental angioplasty: time course and relation to vascular injury. Circulation 1987;75:636-42.
23. 23. Holmsen H. Platelet secretion and energy metabolism. In: Colman RW, Hirsch J, Marder VJ, Salzman EW, editors. Hemostasis and thrombosis: basic principles and clinical practice. Philadelphia: JB Lippincott Co; 1993. p 524-45.
24. 24. Herbert JM, Lamarche I, Dol F. Induction of vascular smooth muscle cell growth by selective activation of the thrombin receptor: effect of heparin. FEBS Lett 1992;301:155-8.
25. 25. Okazaki H, Majesky MW, Harker LA, Schwartz SM. Regulation of platelet-derived growth factor ligand and receptor gene expression by α-thrombin in vascular smooth muscle cells. Circ Res 1992;71:1285-93.
26. 26. Majesky MW, Reidy MA, Bowen-Pope DF, Hart CE, Wilcox JN, Schwartz SM. PDGF ligand and receptor gene expression during repair of arterial injury. J Cell Biol 1990;111:2149-58.
27. 27. Vu TK, Hung DT, Wheaton VI, Coughlin SR. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 1991;64:1057-68.
28. + mobilization. FEBS Lett 1991;288:123-8.
29. 29. Vouret-Craviari V, Van Obberghen-Schilling E, Rasmussen UB, Pavirani A, Lecocq J-P, Pouyssegur J. Synthetic α-thrombin receptor peptides activate G protein-coupled signaling pathways but are unable to induce mitogenesis. Mol Biol Cell 1992;3:95-102.
30. 30. McNamara CA, Sarembock IJ, Gimple LW, Fenton JW II, Coughlin SR, Owens GK. Thrombin stimulates proliferation of cultured rat aortic smooth muscle cells by a preoteolytically activated receptor. J Clin Invest 1993;91:94-8.
31. 31. Nakajima T, Kitajima I, Shin H, Takasaki I, Shingeta K, Abeyama K, et al. Involvement of NF-κB activation in thrombin-induced human vascular smooth muscle cell proliferation. Biochem Biophys Res Commun 1994;204: 958-5.
32. 32. Walters TK, Gorog DA, Wood RFM. Thrombin generation following arterial injury is a critical initiating event in the pathogenesis of the proliferative stages of the atheroscleorotic process. J Vasc Res 1994;31:173-7.
33. 33. Molloy CJ, Pawlowski JE, Taylor DS, Turner CE, Weber H, Peluso M. Thrombin receptor activation elicits rapid protein tyrosine phosphorylation and stimulation of the raf-1/MAP kinase pathway preceding delayed mitogenesis in cultured rat aortic smooth muscle cells: evidence for an obligate autocrine mechanism promoting cell proliferation induced by G-protein coupled receptor agonists. J Clin Invest 1996;97:1173-83.
34. 34. Wilcox JN, Rodriguez J, Subramanian R, Ollerenshaw J, Zhong C, Hayzer DJ, et al. Characterization of thrombin receptor expression during vascular lesion formation. Circ Res 1994;75:1029-38.
35. 35. Zhong C, Hayzer DJ, Corson MA, Runge MS. Molecular cloning of the rat vascular smooth muscle thrombin receptor: evidence for in vitro regulation by basic fibroblast growth factor. J Biol Chem 1992;267:16975-9.
36. 36. Seewald S, Nickenig G, Ko Y, Vetter H, Sachinidis A. Low density lipoprotein enhances the thrombin-induced growth of vascular smooth muscle cells. Cardiovasc Res 1997;36:92-100.
37. 37. Schini-Kerth VB, Fisslthaler B, Van Obberghen-Schilling E, Busse R. Serotonin stimulates the expression of thrombin receptors in cultured vascular smooth muscle cells. Role of protein kinase C and protein tyrosine kinases. Circulation 1996;93:2170-7.
38. 38. Zucker T, Bonisch D, Muck S, Weber AA, Bretschneider E, Glusa E, et al. Thrombin-induced mitogenesis in coronary artery smooth muscle cells is potentiated by thromboxane A2 and involves up-regulation of thromboxane receptor mRNA. Circulation 1998;97:589-95.
39. 39. Kanthou C, Kanse SM, Kakkar VV, Benzakour O. Involvement of pertussis toxin-sensitive and insensitive G proteins in α-thrombin signaling on cultured human vascular smooth muscle cells. Cell Signal 1996;8:59-66.
40. 40. Kavanaugh WM, Williams LT, Ives HE, Coughlin SR. Serotonin-induced deoxyribonucleic acid synthesis in vascular smooth muscle cells involves a novel, pertussis toxin-sensitive pathway. Mol Endocrinol 1988;2:599-605.
41. 41. Gordeladze JO, Johanson PW, Paulssen RH, Paulssen EJ, Gautvik KM. G-proteins: implication for pathophysiology and disease. Eur J Endocrinol 1994;131:557-74.
42. 42. Hepler JR, Gilman AG. G proteins. Trends Biochem Sci 1992;17:383-7.
43. 43. Offermans S, Laugwitz KL, Spicher K, Schulz G. G proteins of the G12 family are activated via the thromboxane A2 and thrombin receptors in human platelets. Proc Natl Acad Sci USA 1994;91:504-8.
44. 44. Dickenson JM, Hill SJ. Human 5-HT1B receptor stimulated inositol phospholipid hydrolysis in CHO cells: synergy with Gq-coupled receptors. Eur J Pharmacol 1998;348:279-85.
45. 45. Hartmann T, Ruoss SJ, Raymond WW, Seuwen K, Caughey GH. Human tryptase as a potent, cell-specific mitogen: role of signaling pathways in synergistic responses. Am J Physiol 1992;262:L528-34.
46. 46. Hoyer D, Clarke DE, Fozard JR, Hartig PR, Martin GR, Mylecharane EJ, et al. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol Rev 1994;46:157-203.
47. 47. Eddahibi S, Fabre V, Boni C, Martres MP, Raffestin B, Hamon M, et al. Induction of serotonin transporter by hypoxia in pulmonary vascular smooth muscle cells relationship with the mitogenic action of serotonin. Circ Res 1999;84: 329-36.
48. 48. Lee SL, Wang WW, Moore BJ, Fanburg BL. Dual effect of serotonin on growth of bovin pulmonary artery smooth muscle cells in culture. Circ Res 1991;68:1362-8.
49. 49. Pakala R, Willerson JT, Benedict CR. Mitogenic effect of serotonin on vascular endothelial cells. Circulation 1994;90: 1919-26.
50. 50. Araki S, Kawahara Y, Fukuzaki H, Takai Y. Serotonin plays a major role in serum-induced phospholipase C-mediated hydrolysis of phosphoinositides and DNA synthesis in vascular smooth muscle cells. Atherosclerosis 1990;83:29-34.
51. 51. Bell L, Madri JA. Effect of platelet factors on migration of cultured bovine aortic endothelial and smooth muscle cells. Circ Res 1989;65:1057-65.
52. 52. Cohen ML, Fuller RW, Kurz KD, Parli CJ, Mason NR, Meyers DB, et al. Preclinical pharmacology of a new serotonergic receptor antagonist, LY281067. J Pharmacol Exp Ther 1988;244:106-12.
53. 53. Lee SL, Wang WW, Lanzillo J, Gillis N, Fanburg BL. Superoxide scavenging effect of ginkgo biloba extract on serotonin-induced mitogenesis. Biochem Pharmacol 1998;56: 527-33.
54. 54. Hedin U, Frebelius S, Sanchez J, Dryjski M, Swedenborg J. Anti-thrombin III inhibits thrombin-induced proliferation in human arterial smooth muscle cells. Arterioscler Thromb 1994;14:254-60.
55. 55. Lindner V, Olson NE, Clowes AW, Reidy MA. Inhibition of smooth muscle cell proliferation in injured rat arteries: interaction of heparin with basic fibroblast growth factor. J Clin Invest 1992;90:2044-9.
56. 56. McCaffrey TA, Falcone DJ, Brayton CF. Transforming growth factor-β activity is potentiated by heparin via dissociation of the transforming growth factor beta/alpha2-macroglobulin inactive complex. J Cell Biol 1989;109: 441-8.
57. 57. Gerdes C, Faber-Steinfeld V, Yalkinoglu O, Wohlfeil S. Comparison of the effects of the thrombin inhibitor r-hirudin in four animal models of neointimal formation after arterial injury. Arteriocler Thromb Vasc Biol 1996;16: 1306-11.
58. 58. Webster MWI, Chesebro JH, Grill DE, Badimon JJ, Badimon L, Fuster V. The thrombotic and proliferative response to angioplasty in pigs after deep arterial injury: effect of intravenous thrombin inhibition with hirudin. Circulation 1991;84(suppl II):II-580.
59. 59. Unterberg C, Sandrock D, Nebendahl K, Buchwald AB. Reduced acute thrombus formation results in decreased neointimal proliferation after coronary angioplasty. J Am Coll Cardiol 1995;26:1747-54.
60. 60. Ip JH, Fuster V, Israel D, Badimon L, Badimon J, Chesebro JH. The role of platelets, thrombin and hyperplasia in restenosis after coronary angioplasty. J Am Coll Cardiol 1991;17:77B-88B.
61. 61. Serruys PK, Klein W, Tijssen JPG, Rutsch W, Heyndrickx GR, Emanuelsson H, et al. Evaluation of ketanserin in the prevention of restenosis after percutanenous transluminal coronary angioplasty: a multicenter randomized double-blind placebo-controlled trial. Circulation 1993;88:1588-601.
62. 62. Serruys PW, Herrman J-PR, Simon R, Rutsch W, Bode C, Laarman G-J, et al for the HELVETICA investigators. A comparison of hirudin with heparin in the prevention of restenosis after coronary angioplasty. N Engl J Med 1995; 333:757-63.
63. 63. Levi M. Thrombin or platelets as a major point of impact in vascular reocclusion and restenosis: a controversy? Cardiovasc Res 1996;31:231.